Sector
PharmaceuticalsOpen
₹25Prev. Close
₹26.02Turnover(Lac.)
₹4.92Day's High
₹26.75Day's Low
₹24.7252 Week's High
₹27.552 Week's Low
₹8.74Book Value
₹6.65Face Value
₹10Mkt Cap (₹ Cr.)
38.03P/E
49.09EPS
0.53Divi. Yield
016 Sep 2024
12:00 AM
BookCloser
17 Sep 2024
12:00 AM
AGM
Announcement Date: 17 Sep, 2024
28 Dec 2023
12:00 AM
EGM
18 Jan 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 14.18 | 4.88 | 4.88 | 4.88 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -5.64 | -5.72 | -5.76 | -5.77 |
Net Worth | 8.54 | -0.84 | -0.88 | -0.89 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 0.01 | 0 | 0 | 1.56 |
yoy growth (%) | 0 | 0 | -100 | 9,330.96 |
Raw materials | 0 | 0 | 0 | -1.5 |
As % of sales | 77.22 | 0 | 0 | 96.22 |
Employee costs | 0 | -0.01 | -0.02 | -0.03 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -0.1 | 0 | -0.01 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
Tax paid | 0 | 0 | 0 | 6.4 |
Working capital | 0 | -0.01 | 0.01 | 0.01 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | -100 | 9,330.96 |
Op profit growth | 457.54 | -70.39 | -791.1 | 1,587.44 |
EBIT growth | 1,944.45 | -69.78 | -271.28 | 1,587.44 |
Net profit growth | 1,944.45 | -69.78 | -270.19 | -99.56 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,821.9 | 159.62 | 4,40,050.03 | 863.29 | 0.74 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,766.2 | 84.49 | 1,55,207.53 | 518 | 0.51 | 2,302 | 513.62 |
Cipla Ltd CIPLA | 1,411.8 | 27.68 | 1,17,196.91 | 1,178.16 | 0.9 | 3,969.86 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,247.75 | 67.57 | 1,10,538.08 | 460 | 0.86 | 2,376 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,505.85 | 54.19 | 1,08,616.49 | 634.43 | 0 | 2,529.74 | 334.18 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole Time Director & CFO
Murli Shivshankaran Nair
Non Executive Director
Reena Mahatma
Independent Director
Narayansinh Padudansinh Chauhan
Independent Director
Gautam Keshavlal Chauhan
Company Sec. & Compli. Officer
Manmeetkaur Harshdeepsingh Bhatia
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Gujarat Inject (Kerala) Ltd
Summary
Gujarat Inject Kerala Limited was incorporated in Jan. 91. In 2004-05, Company started production of I.V. FIuids in April, 2005.
Read More
What is the Gujarat Inject Kerala Ltd share price today?
The Gujarat Inject Kerala Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹25.96 today.
What is the Market Cap of Gujarat Inject Kerala Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gujarat Inject Kerala Ltd is ₹38.03 Cr. as of 24 Jan ‘25
What is the PE and PB ratio of Gujarat Inject Kerala Ltd?
The PE and PB ratios of Gujarat Inject Kerala Ltd is 49.09 and 3.91 as of 24 Jan ‘25
What is the 52 Week High and Low of Gujarat Inject Kerala Ltd?
The 52-week high/low is the highest and lowest price at which a Gujarat Inject Kerala Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Gujarat Inject Kerala Ltd is ₹8.74 and ₹27.5 as of 24 Jan ‘25
What is the CAGR of Gujarat Inject Kerala Ltd?
Gujarat Inject Kerala Ltd's CAGR for 5 Years at N/I%, 3 Years at 120.41%, 1 Year at 65.10%, 6 Month at 72.89%, 3 Month at 40.27% and 1 Month at 1.25%.
What is the shareholding pattern of Gujarat Inject Kerala Ltd?
The shareholding pattern of Gujarat Inject Kerala Ltd is as follows:
Promoters - 0.00 %
Institutions - 0.00 %
Public - 100.00 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
